Study summary
Catheter repair of a leaky tricuspid valve halved death or hospital stays
52.4%free of death or heart failure hospitalization at 3 years, vs 21.0%
What was tested
Transcatheter tricuspid valve repair plus medicines against medicines alone in symptomatic severe tricuspid regurgitation.
What they found
- Freedom from death or heart failure hospitalization at 3 years was 52.4% vs 21.0%.
- Major problems within 30 days occurred in 5.9%.
What it means
Supports earlier valve repair for people with a severely leaking tricuspid valve.
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.